Cargando…
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Autores principales: | Zhang, Ning, Wang, Hanjie, Yang, Jili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044007/ https://www.ncbi.nlm.nih.gov/pubmed/32100488 http://dx.doi.org/10.3802/jgo.2020.31.e43 |
Ejemplares similares
-
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
por: Park, Young-Chul, et al.
Publicado: (2019) -
Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial
por: Koeneman, M. M., et al.
Publicado: (2017) -
Infrared Coagulation: A Treatment Option for Cervical Intraepithelial
Neoplasia
por: Vassiliu, Pantelis, et al.
Publicado: (2017) -
Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia
por: He, Yue, et al.
Publicado: (2017) -
Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia
por: Kim, Ju-Hyun, et al.
Publicado: (2022)